Jazz Pharmaceuticals plc Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Jazz Pharmaceuticals plc quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Jazz Pharmaceuticals plc Current Ratio for the quarter ending September 30, 2024 was 265 %, a 0.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 265 -2.39 -0.9% Sep 30, 2024
Q2 2024 223 -81.5 -26.8% Jun 30, 2024
Q1 2024 236 -78.5 -25% Mar 31, 2024
Q4 2023 251 -70.7 -22% Dec 31, 2023
Q3 2023 267 -68.1 -20.3% Sep 30, 2023
Q2 2023 305 -41.1 -11.9% Jun 30, 2023
Q1 2023 314 -24.1 -7.14% Mar 31, 2023
Q4 2022 322 -35.6 -9.95% Dec 31, 2022
Q3 2022 335 -48.3 -12.6% Sep 30, 2022
Q2 2022 346 -47.4 -12% Jun 30, 2022
Q1 2022 338 -104 -23.5% Mar 31, 2022
Q4 2021 358 -80.8 -18.4% Dec 31, 2021
Q3 2021 384 -58.1 -13.2% Sep 30, 2021
Q2 2021 393 -53.3 -11.9% Jun 30, 2021
Q1 2021 442 +44.9 +11.3% Mar 31, 2021
Q4 2020 438 +59.7 +15.8% Dec 31, 2020
Q3 2020 442 +84.3 +23.6% Sep 30, 2020
Q2 2020 447 +81 +22.2% Jun 30, 2020
Q1 2020 397 +30.5 +8.33% Mar 31, 2020
Q4 2019 379 +14.9 +4.09% Dec 31, 2019
Q3 2019 357 -0.71 -0.2% Sep 30, 2019
Q2 2019 366 +36.3 +11% Jun 30, 2019
Q1 2019 367 +64.6 +21.4% Mar 31, 2019
Q4 2018 364 +97.2 +36.4% Dec 31, 2018
Q3 2018 358 +102 +39.8% Sep 30, 2018
Q2 2018 329 +72.7 +28.3% Jun 30, 2018
Q1 2018 302 -11.2 -3.59% Mar 31, 2018
Q4 2017 267 -91.2 -25.5% Dec 31, 2017
Q3 2017 256 -159 -38.3% Sep 30, 2017
Q2 2017 257 -169 -39.7% Jun 30, 2017
Q1 2017 313 -114 -26.7% Mar 31, 2017
Q4 2016 358 -128 -26.3% Dec 31, 2016
Q3 2016 415 -51.6 -11% Sep 30, 2016
Q2 2016 426 -53.1 -11.1% Jun 30, 2016
Q1 2016 427 +14.9 +3.6% Mar 31, 2016
Q4 2015 486 +149 +44% Dec 31, 2015
Q3 2015 467 +142 +43.6% Sep 30, 2015
Q2 2015 479 +154 +47.5% Jun 30, 2015
Q1 2015 412 +59.8 +16.9% Mar 31, 2015
Q4 2014 337 -28.4 -7.77% Dec 31, 2014
Q3 2014 325 -8.46 -2.54% Sep 30, 2014
Q2 2014 325 +34.2 +11.8% Jun 30, 2014
Q1 2014 353 +119 +50.9% Mar 31, 2014
Q4 2013 366 +131 +56% Dec 31, 2013
Q3 2013 333 +104 +45.3% Sep 30, 2013
Q2 2013 290 +50.1 +20.8% Jun 30, 2013
Q1 2013 234 -41.1 -15% Mar 31, 2013
Q4 2012 235 Dec 31, 2012
Q3 2012 229 Sep 30, 2012
Q2 2012 240 Jun 30, 2012
Q1 2012 275 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.